Joint Statements/Positions

Joint statement from the human pharmaceutical industry on the Urban Wastewater Treatment Directive (2024) View
Joint Statements/Positions

Joint statement from the human pharmaceutical industry on the Urban Wastewater Treatment Directive (2024)

Read more
Joint stakeholder statement on the implementation of the EHDS (2024) View
Joint Statements/Positions

Joint stakeholder statement on the implementation of the EHDS (2024)

Read more
Joint Position Paper on Patient information on medicinal products – how to make it patient-centric? (2024) View
Joint Statements/Positions

Joint Position Paper on Patient information on medicinal products – how to make it patient-centric? (2024)

Read more
Multi-stakeholder statement on View
Joint Statements/Positions

Multi-stakeholder statement on "Draft text of the European Health Data Space (EHDS) in trilogues sparks deep concerns in the European healthcare ecosystem" (2024)

Read more
Joint statement supporting the expansion of the use of Electronic Instructions For Use (eIFU) in the medical devices sector (2024) View
Joint Statements/Positions

Joint statement supporting the expansion of the use of Electronic Instructions For Use (eIFU) in the medical devices sector (2024)

Read more
Joint open letter: In anticipation of EUDAMED availability for mandatory use (2023) View
Joint Statements/Positions

Joint open letter: In anticipation of EUDAMED availability for mandatory use (2023)

Read more
Stakeholder coalition calls for legislative refinement of the EHDS (2023) View
Joint Statements/Positions

Stakeholder coalition calls for legislative refinement of the EHDS (2023)

Read more
Medical Devices - Manufacturer’s Declaration in relation to Regulation (EU) 2023/607 View
Guidance

Medical Devices - Manufacturer’s Declaration in relation to Regulation (EU) 2023/607

Read more
Joint Statement on the Packaging and Packaging Waste Regulation's Single Market Legal Basis (2023) View
Joint Statements/Positions

Joint Statement on the Packaging and Packaging Waste Regulation's Single Market Legal Basis (2023)

Read more
White Paper “Balancing challenges on Environment with access to medicines in Europe”: Impact assessment of policy options for Pharmaceuticals in the Environment and the use of Extended Producer Responsibility applied to human medicines (2023) View
Joint Statements/Positions

White Paper “Balancing challenges on Environment with access to medicines in Europe”: Impact assessment of policy options for Pharmaceuticals in the Environment and the use of Extended Producer Responsibility applied to human medicines (2023)

Read more
Extended Environmental Risk Assessment (eERA) proposal: Proactively managing the environmental risks associated with the patient use of human medicinal products (2023) View
Joint Statements/Positions

Extended Environmental Risk Assessment (eERA) proposal: Proactively managing the environmental risks associated with the patient use of human medicinal products (2023)

Read more
Technical Guidance on Responsible Manufacturing Effluent Management (2023) View
Guidance

Technical Guidance on Responsible Manufacturing Effluent Management (2023)

Read more
Joint Statement on the Urban Waste Water Treatment Directive Proposal (2022) View
Joint Statements/Positions

Joint Statement on the Urban Waste Water Treatment Directive Proposal (2022)

Read more
Inter-Association Policy Statement on Responsible Manufacturing Effluent Management (2022) View
Joint Statements/Positions

Inter-Association Policy Statement on Responsible Manufacturing Effluent Management (2022)

Read more
Eco-Pharmaco-Stewardship (EPS) Brochure (2022) View
Joint Statements/Positions

Eco-Pharmaco-Stewardship (EPS) Brochure (2022)

Read more
European Stakeholder Group Statement - Maintaining the exchange of critical health data View
Joint Statements/Positions

European Stakeholder Group Statement - Maintaining the exchange of critical health data

Read more
Joint Industry Letter on EU Standardisation Policy View
Joint Statements/Positions

Joint Industry Letter on EU Standardisation Policy

Read more
AESGP, EFPIA and Medicines for Europe reflections on EMA – HMA – EC Key principles for electronic product information View
Joint Statements/Positions

AESGP, EFPIA and Medicines for Europe reflections on EMA – HMA – EC Key principles for electronic product information

Read more
European Pharmaceutical Industry Statement on the Update on the Progress and Implementation of the EU Strategic Approach to Pharmaceuticals in the Environment View
Joint Statements/Positions

European Pharmaceutical Industry Statement on the Update on the Progress and Implementation of the EU Strategic Approach to Pharmaceuticals in the Environment

Read more
Joint EU-UK pharmaceutical industry response to Specialised Committee outcome View
Joint Statements/Positions

Joint EU-UK pharmaceutical industry response to Specialised Committee outcome

Read more
EU Health Coalition: 10 recommendations to build a stronger EU Health Union View
Joint Statements/Positions

EU Health Coalition: 10 recommendations to build a stronger EU Health Union

Read more
EU Pharma Industry's joint statement on the European Parliament’s Resolution on Pharmaceuticals in the Environment View
Joint Statements/Positions

EU Pharma Industry's joint statement on the European Parliament’s Resolution on Pharmaceuticals in the Environment

Read more
Joint Letter on the Need for a Mutual Recognition Agreement between the EU and UK View
Joint Statements/Positions

Joint Letter on the Need for a Mutual Recognition Agreement between the EU and UK

Read more
European Industry trade and supply chain needs to respond to COVID-19 View
Joint Statements/Positions

European Industry trade and supply chain needs to respond to COVID-19

Read more
EU Health Coalition calls for more solidarity and coordinated EU action to tackle COVID-19 View
Joint Statements/Positions

EU Health Coalition calls for more solidarity and coordinated EU action to tackle COVID-19

Read more
Pharma industry calls for Mutual Recognition on GMP between EU and UK View
Joint Statements/Positions

Pharma industry calls for Mutual Recognition on GMP between EU and UK

Read more
AESGP - Medicines for Europe Joint Position: Why is now the right time to modernise the EU variations system? View
Joint Statements/Positions

AESGP - Medicines for Europe Joint Position: Why is now the right time to modernise the EU variations system?

Read more
Addressing the root causes of medicines shortages View
Joint Statements/Positions

Addressing the root causes of medicines shortages

Read more